Tuberous Sclerosis
TSC Alliance
Type of Organization: Foundation
Contact Name: Dean J. Aguiar, PhD
Email Address: daguiar@tscalliance.org
Funds Available for Clinical Trials:
✗ Research:
✔
Funding Details
Requirements: Directed by Dean Aguiar, PhD, (Vice President, Translational Research) who has more than 20 years in drug design from his previous work in pharma and scientific foundations, the consortium delivers quality in drug testing by:
Ensuring the reproducibility of models and assays
License negotiation and management
Study oversight for quality control
Data interpretation assistance
Other info: The TSC Preclinical Consortium is a partnership with TSC researchers in industry and academia, designed to facilitate the evaluation of novel and repurposed therapeutics for their effectiveness and safety in animal models of TSC. The goal is to advance those therapeutics with compelling effectiveness and safety are advanced to clinical trials.